Jiangsu Nhwa Pharmaceutical Co., LTD (SHE: 002262)
China
· Delayed Price · Currency is CNY
24.35
-0.50 (-2.01%)
Dec 31, 2024, 3:04 PM CST
Jiangsu Nhwa Pharmaceutical Co., LTD Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.38B CNY in the quarter ending September 30, 2024, with 10.07% growth. This brings the company's revenue in the last twelve months to 5.53B, up 14.41% year-over-year. In the year 2023, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.04B with 17.28% growth.
Revenue (ttm)
5.53B
Revenue Growth
+14.41%
P/S Ratio
4.29
Revenue / Employee
1.03M
Employees
5,394
Market Cap
23.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
Dec 31, 2020 | 3.36B | -788.01M | -18.99% |
Dec 31, 2019 | 4.15B | 291.14M | 7.55% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |